Breaking News

Kodak Moves Into Pharma Backed by $765M Federal Loan

Kodak Pharmaceuticals will produce critical pharmaceutical components that have been identified as essential but have lapsed into chronic national shortage.

By: Contract Pharma

Contract Pharma Staff

At the direction of President Donald J. Trump, U.S. International Development Finance Corporation (DFC) chief executive officer Adam Boehler has signed a letter of interest (LOI) to provide a $765 million loan to Eastman Kodak Company to support the launch of Kodak Pharmaceuticals, a new arm of the company that will produce critical pharmaceutical components. The project would mark the first use of new authority delegated by President Trump’s recent executive order that enables DFC and the U.S. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters